Skip to main content

The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research Centers

Agency: National Institutes of Health

Assistance Listings
  • 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research

Forecasted opportunityLast Updated: May 13, 2026

Important dates

  • Forecasted post date: August 1, 2026
  • Forecasted application due date: November 1, 2026
  • Forecasted award date: July 1, 2027
  • Forecasted project start date: July 1, 2027
  • Fiscal Year: 2027

Award details

  • Expected project funding: $6,400,000
  • Expected awards: 9

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:RFA-DK-27-116
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Cooperative agreement
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: September 18, 2025
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

The National Institute of Diabetes and Digestive Diseases and Nutrition (NIDDK) seeks to advance its mission by continuing the NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC). The IBDGC has led collaborative efforts resulting in the identification of >300 genetic risk loci for different IBD subtypes across patient populations and characterization of underlying biological mechanisms. Despite advances in biological understanding and the development of a range of biologic therapies, IBD remains a chronic, severe and heterogenous disease with no cure requiring multiple interventions over the life course. Diagnostic biomarkers and accurate predictors of critical outcomes including disease remission, recurrence, and response to specific therapies are lacking. The IBDGC will leverage patient cohorts, biospecimens and advances in data science to characterize the interactions of genetic, clinical and environmental factors in disease development and progression, and to develop new predictors of disease outcomes, with the goal of improving medical management and advancing precision medicine for IBD patients. The IBDGC may include up to 7 Genomic Research Centers with varying research emphases, which will serve as sites for participant enrollment, molecular analysis of biospecimens and bioinformatics and computational analyses.  

Eligibility

Miscellaneous

  • Other

Business

  • For-profit organizations other than small businesses
  • Small businesses

Government

  • County governments
  • State governments
  • Special district governments
  • Public and Indian housing authorities
  • City or township governments
  • Federally recognized Native American tribal governments

Education

  • Independent school districts
  • Public and state institutions of higher education
  • Private institutions of higher education

Nonprofit

  • Other Native American tribal organizations
  • Nonprofits non-higher education with 501(c)(3)

Additional information on eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Documents

No documents are currently available.

Agency contact information

Email: Ludmila.pawlikowska@nih.gov

Ludmila.pawlikowska@nih.gov

Ludmila Pawlikowska Ph.D. 301-480-9372

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov